Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are over 18 years old
- People who have a PSA (prostate-specific antigen) blood test result between 4 and 20 ng/ml, and/or an abnormal digital rectal exam (a physical check of the prostate)
- People who are willing to sign a consent form agreeing to take part in the trial
Who may not be able to join:
- People who have acute (sudden) or chronic (long-term) prostatitis (inflammation of the prostate)
- People for whom a prostate biopsy (taking a small tissue sample from the prostate) would be medically unsafe or unsuitable
- People for whom an MRI scan would be medically unsafe or unsuitable (for example, due to certain metal implants)
- People who have other reasons that the trial site considers make them unsuitable for this trial (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Haifeng Wang, MD, Shanghai East Hospital of Tongji University
Phone: +8615502139410
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The detection rate of clinically significant prostate cancer for targeted biopsy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.